Results 161 to 170 of about 7,268 (215)

Translational approaches to the study of eosinophils in vasculitis. [PDF]

Rheumatology (Oxford)
Egan A, Khoury P.
europepmc   +1 more source

Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma. [PDF]

Clin Pharmacokinet
Jin Y, Guiastrennec B, Stuke M, Yao Y, Zhang Y, Barker P, Jison M, Penland RC, Ding J, Lukka PB.   +9 more
europepmc   +1 more source

Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction. [PDF]

J Asthma Allergy
González-Tuyub YH, González-Iñiguez KD, Lizarazo-Guiza PC, García-García SR.   +3 more
europepmc   +1 more source

Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A 32-Week Evaluation.

Int Arch Allergy Immunol
Özden Ş, Tepetam FM, Bozkurt Y, Terzioğlu Şahin F, Aynacı A, Avcı HF, Dursun M, Demirkol MA, Yıldırım N.   +8 more
europepmc   +1 more source

Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. [PDF]

Biomedicines
Damiański P, Białas AJ, Kołacińska-Flont M, Elgalal A, Jarmakowska K, Kierszniewska D, Panek M, Kardas G, Kuna P, Kupczyk M.   +9 more
europepmc   +1 more source

Use of CompEx in eosinophilic patients with severe, uncontrolled asthma on benralizumab.

ERJ Open Res
Bolton C, Harrison T, Lugogo N, Fuhlbrigge A, Hirsch I, Bengtsson T, Peterson S, Sidaway M, Garcia Gil E, Fagerås M, Da Silva CA.   +10 more
europepmc   +1 more source

Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan. [PDF]

Drugs
Lombardi C, Comberiati P, Ridolo E, Cottini M, Yacoub MR, Casagrande S, Riccò M, Bottazzoli M, Berti A.   +8 more
europepmc   +1 more source

Biologics in severe asthma: a state-of-the-art review. [PDF]

Eur Respir Rev
Gyawali B, Georas SN, Khurana S.
europepmc   +1 more source

La calima

, 2004
openaire   +1 more source

THE AUTHORS RESPOND. [PDF]

J Manag Care Spec Pharm
Xu X, Katial R, Schaefer C, Szende A, Genofre E, Chung Y.   +5 more
europepmc   +1 more source